Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wakunaga of America, widely known by its flagship brand Kyolic, is a leader in the development and manufacturing of high-quality herbal supplements and natural medicines. The company is best known for its Aged Garlic Extract (AGE), a proprietary ingredient produced through a unique aging process that converts harsh sulfur compounds into stable, odorless antioxidants. Backed by over 900 peer-reviewed scientific studies, Wakunaga's products target cardiovascular health, immune support, and overall wellness. The company maintains rigorous quality control standards, including ISO 9001 and GMP certifications, ensuring the safety and efficacy of its diverse product line. Headquartered in California, Wakunaga operates as a subsidiary of the Japan-based Wakunaga Pharmaceutical Co., Ltd.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kyolic.